These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 19538804

  • 1. Using the differential from complete blood counts as a biomarker of fatigue in advanced non-small-cell lung cancer: an exploratory analysis.
    Paddison JS, Temel JS, Fricchione GL, Pirl WF.
    Palliat Support Care; 2009 Jun; 7(2):213-7. PubMed ID: 19538804
    [Abstract] [Full Text] [Related]

  • 2. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer.
    Brown DJ, McMillan DC, Milroy R.
    Cancer; 2005 Jan 15; 103(2):377-82. PubMed ID: 15558809
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.
    Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Furuse K, Fukushima M.
    Eur J Cancer; 2009 Jul 15; 45(11):1950-8. PubMed ID: 19231158
    [Abstract] [Full Text] [Related]

  • 4. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
    Res Rep Health Eff Inst; 2009 Mar 15; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [Abstract] [Full Text] [Related]

  • 5. Fatigue during breast radiotherapy and its relationship to biological factors.
    Wratten C, Kilmurray J, Nash S, Seldon M, Hamilton CS, O'Brien PC, Denham JW.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):160-7. PubMed ID: 15093912
    [Abstract] [Full Text] [Related]

  • 6. Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.
    Blumenschein GR, Gatzemeier U, Fossella F, Stewart DJ, Cupit L, Cihon F, O'Leary J, Reck M.
    J Clin Oncol; 2009 Sep 10; 27(26):4274-80. PubMed ID: 19652055
    [Abstract] [Full Text] [Related]

  • 7. Activated changes of platelet ultra microstructure and plasma granule membrane protein 140 in patients with non-small cell lung cancer.
    Zhuge Y, Zhou JY, Yang GD, Zu DL, Xu XL, Tian MQ, Lu GH.
    Chin Med J (Engl); 2009 May 05; 122(9):1026-31. PubMed ID: 19493436
    [Abstract] [Full Text] [Related]

  • 8. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D, Golubicic I, Gavrilovic D, Kezic I, Jelic S.
    J BUON; 2009 May 05; 14(2):203-9. PubMed ID: 19650167
    [Abstract] [Full Text] [Related]

  • 9. Platelet linoleic acid is a potential biomarker of advanced non-small cell lung cancer.
    de Castro J, Rodríguez MC, Martínez-Zorzano VS, Llanillo M, Sánchez-Yagüe J.
    Exp Mol Pathol; 2009 Dec 05; 87(3):226-33. PubMed ID: 19733167
    [Abstract] [Full Text] [Related]

  • 10. Do beta-blockers alter dyspnea and fatigue in advanced lung cancer? A retrospective analysis.
    Cameron P, Ellis PM, Pond GR, Goffin JR.
    Palliat Med; 2012 Sep 05; 26(6):797-803. PubMed ID: 21844136
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.
    Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884
    [Abstract] [Full Text] [Related]

  • 12. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy.
    Sekine I, Sumi M, Ito Y, Tanai C, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T.
    Jpn J Clin Oncol; 2009 Nov 15; 39(11):707-12. PubMed ID: 19692418
    [Abstract] [Full Text] [Related]

  • 13. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX, Hou X, Lin P, Rong TH, Yang H, Fu JH.
    Ann Thorac Surg; 2009 Aug 15; 88(2):372-8. PubMed ID: 19632375
    [Abstract] [Full Text] [Related]

  • 14. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review.
    Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE.
    Brain Behav Immun; 2007 May 15; 21(4):413-27. PubMed ID: 17178209
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
    Schiller JH, Larson T, Ou SH, Limentani S, Sandler A, Vokes E, Kim S, Liau K, Bycott P, Olszanski AJ, von Pawel J.
    J Clin Oncol; 2009 Aug 10; 27(23):3836-41. PubMed ID: 19597027
    [Abstract] [Full Text] [Related]

  • 16. Modafinil for the treatment of fatigue in lung cancer: a pilot study.
    Spathis A, Dhillan R, Booden D, Forbes K, Vrotsou K, Fife K.
    Palliat Med; 2009 Jun 10; 23(4):325-31. PubMed ID: 19270033
    [Abstract] [Full Text] [Related]

  • 17. Survival of patients with true pathologic stage I non-small cell lung cancer.
    Cerfolio RJ, Bryant AS.
    Ann Thorac Surg; 2009 Sep 10; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
    [Abstract] [Full Text] [Related]

  • 18. Preoperative leukocytosis, anemia and thrombocytosis are associated with poor survival in non-small cell lung cancer.
    Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T.
    Anticancer Res; 2009 Jul 10; 29(7):2687-90. PubMed ID: 19596947
    [Abstract] [Full Text] [Related]

  • 19. Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
    Ratto GB, Costa R, Maineri P, Alloisio A, Bruzzi P, Dozin B.
    J Thorac Cardiovasc Surg; 2009 Oct 10; 138(4):849-58. PubMed ID: 19660370
    [Abstract] [Full Text] [Related]

  • 20. Does sex make a difference in survival of patients undergoing resection for early stage non-small cell lung cancer (NSCLC)?
    Jubelirer SJ, Varela NL, Welch CA, Emmett MK.
    W V Med J; 2009 Oct 10; 105(4):18-22. PubMed ID: 19585900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.